Your browser doesn't support javascript.
loading
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Armstrong, Terri S; Dirven, Linda; Arons, David; Bates, Amanda; Chang, Susan M; Coens, Corneel; Espinasse, Claire; Gilbert, Mark R; Jenkinson, David; Kluetz, Paul; Mendoza, Tito; Rubinstein, Larry; Sul, Joohee; Weller, Michael; Wen, Patrick Y; van den Bent, Martin J; Taphoorn, Martin J B.
Afiliação
  • Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: terri.armstrong@nih.gov.
  • Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
  • Arons D; National Brain Tumor Society, Newton, MA, USA.
  • Bates A; National Brain Tumor Society, Newton, MA, USA.
  • Chang SM; Division of Neuro Oncology, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Coens C; Statistical Department, European Organization for the Outcomes and Treatment of Cancer Headquarters, Brussels, Belgium.
  • Espinasse C; Scientific and Regulatory Management, European Medicines Agency, Amsterdam, Netherlands.
  • Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Jenkinson D; The Brain Tumour Charity, Farnborough, UK.
  • Kluetz P; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
  • Mendoza T; Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rubinstein L; Biometric Research Program, National Cancer Institute, Bethesda, MD, USA.
  • Sul J; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
  • Weller M; Department of Neurology, Institution University Hospital and University of Zurich, Zurich, Switzerland.
  • Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • van den Bent MJ; Erasmus University MC Cancer Institute, Rotterdam, Netherlands.
  • Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
Lancet Oncol ; 21(2): e97-e103, 2020 02.
Article em En | MEDLINE | ID: mdl-32007210
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Atenção à Saúde / Avaliação de Resultados da Assistência ao Paciente / Medidas de Resultados Relatados pelo Paciente / Glioma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Atenção à Saúde / Avaliação de Resultados da Assistência ao Paciente / Medidas de Resultados Relatados pelo Paciente / Glioma Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article